Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine

被引:32
作者
Billaut-Mulot, O
Idziorek, T
Ban, E
Kremer, L
Dupré, L
Loyens, M
Riveau, G
Locht, C
Capron, A
Bahr, GM
机构
[1] Inst Pasteur Lille, Unite Inserm 167, F-59019 Lille, France
[2] Inst Pasteur Lille, Unite Inserm 447, F-59019 Lille, France
关键词
DNA vaccination; IL-18; HIV;
D O I
10.1016/S0264-410X(00)00157-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many different HIV-1 vaccine strategics have been developed, but as yet none has been completely successful. Promising results from combined DNA prime/protein boost vaccines have been reported. Specific immune responses generated by DNA vaccines carl be modulated by the co-delivery of genes coding for cytokines, In this study, we have used the intradermal route by needle injection of a plasmid coding for the HIV-1 Nef accessory protein. We show that DNA prime/protein boost vaccine combinations increase the humoral and cellular immune responses against HIV-1 Nef and that the co-injection of DNA encoding Interleukin-18 (IL-18) modulates the specific immune response towards a Th1 type, (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 32 条
[1]   An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV [J].
Agadjanyan, MG ;
Trivedi, NN ;
Kudchodkar, S ;
Bennet, M ;
Levine, W ;
Lin, A ;
Boyer, J ;
Levy, D ;
Ugen, KE ;
Kim, JJ ;
Weiner, DB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (18) :1561-1572
[2]  
Asakura Y, 1996, AM J HEMATOL, V53, P116, DOI 10.1002/(SICI)1096-8652(199610)53:2&lt
[3]  
116::AID-AJH9&gt
[4]  
3.0.CO
[5]  
2-2
[6]   DNA-plasmids of HIV-1 induce systemic and mucosal immune responses [J].
Asakura, Y ;
Lundholm, P ;
Kjerrström, A ;
Benthin, R ;
Lucht, E ;
Fukushima, J ;
Schwartz, S ;
Okuda, K ;
Wahren, B ;
Hinkula, J .
BIOLOGICAL CHEMISTRY, 1999, 380 (03) :375-379
[7]   Vaccination with HIV 1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit [J].
Barnett, SW ;
Rajasekar, S ;
Legg, H ;
Doe, B ;
Fuller, DH ;
Haynes, JR ;
Walker, CM ;
Steimer, KS .
VACCINE, 1997, 15 (08) :869-873
[8]  
Barouch DH, 1998, J IMMUNOL, V161, P1875
[9]   A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation [J].
Caver, TE ;
Lockey, TD ;
Srinivas, RV ;
Webster, RG ;
Hurwitz, JL .
VACCINE, 1999, 17 (11-12) :1567-1572
[10]   OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE [J].
CHOWERS, MY ;
SPINA, CA ;
KWOH, TJ ;
FITCH, NJS ;
RICHMAN, DD ;
GUATELLI, JC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2906-2914